As a 501(c)(3) nonprofit, we depend almost entirely on donations from people like you.
We really need your help to continue this work! Please consider making a donation.
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

NIH scientists made $710M in royalties from drug makers — a fact they tried to hide
Key Excerpts from Article on Website of New York Post


New York Post, June 2, 2024
Posted: June 11th, 2024
https://nypost.com/2024/06/02/opinion/nih-scientists-made-71...

New data from the National Institutes of Health reveal the agency and its scientists collected $710 million in royalties during the pandemic, from late 2021 through 2023. These are payments made by private companies, like pharmaceuticals, to license medical innovations from government scientists. Almost all that cash — $690 million — went to the National Institute of Allergy and Infectious Diseases, the subagency led by Dr. Anthony Fauci, and 260 of its scientists. Information about this vast private royalty complex is tightly held by the National Institutes of Health (NIH). My organization, OpenTheBooks.com, was forced to sue to uncover the royalties paid from September 2009 to October 2021, which amounted to $325 million over 56,000 transactions. Payments skyrocketed during the pandemic era: Those years saw more than double the amount of cash flow to NIH from the private sector, compared to the prior 12 combined. All told, it’s $1.036 billion. NIH is still redacting pieces of the data that would help us more easily connect therapeutics with their government-paid inventors. For example, they refuse to show us the amount of royalties paid to each individual scientist. So we still can’t entirely follow the money. In the meantime, Sen. Rand Paul (R-Ky.) has sponsored the Royalty Transparency Act, which sailed unanimously through the committee process and deserves a floor vote immediately.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.


Latest News


Key News Articles from Years Past